Vaccines meet big data: State-ofthe- Art and future prospects. From the classical 3is ("isolate-inactivate- inject") vaccinology 1.0 to vaccinology 3.0, vaccinomics, and Beyond: A historical overview

Frontiers in Public Health

Volumn 6, Issue , 2018, Pages

  Bragazzi, Nicola Luigi ^a   Gianfredi, Vincenza ^b   Villarini, Milena ^b   Rosselli, Roberto ^c   Nasr, Ahmed ^d   Hussein, Amr ^e   Martini, Mariano ^a   Behzadifar, Masoud ^f  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Division of Rheumatology ASL3 Genovese   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Big Data; EHealth; History of vaccinology; Omics disciplines; Vaccine; Web 2.0

Indexed keywords

EID: 85043389540     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2018.00062     Document Type: Short Survey

References (111)

1. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 86(2):140-6. doi:10.2471/BLT.07.040089
2. Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, et al. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. Vaccine (2013) 31(Suppl 2):B61-72. doi:10.1016/j.vaccine.2012.11.035
3. Lee BY, Bartsch SM, Brown ST, Cooley P, Wheaton WD, Zimmerman RK. Quantifying the economic value and quality of life impact of earlier influenza vaccination. Med Care (2015) 53(3):218-29. doi:10.1097/MLR. 0000000000000302
4. Ehreth J. The global value of vaccination. Vaccine (2003) 21:596-600. doi:10.1016/S0264-410X(02)00623-0
5. Hagan T, Nakaya HI, Subramaniam S, Pulendran B. Systems vaccinology: enabling rational vaccine design with systems biological approaches. Vaccine (2015) 33:5294-301. doi:10.1016/j.vaccine.2015.03.072
6. Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature (2011) 473(7348):463-9. doi:10.1038/nature10124
7. Gutiérrez AH, Spero DM, Gay C, Zimic M, De Groot AS. New vaccines needed for pathogens infecting animals and humans: One Health. Hum Vaccin Immunother (2012) 8(7):971-8. doi:10.4161/hv.20202
8. Neiderud CJ. How urbanization affects the epidemiology of emerging infectious diseases. Infect Ecol Epidemiol (2015) 5:27060. doi:10.3402/iee. v5.27060
9. Rhee JH. Towards vaccine 3.0: new era opened in vaccine research and industry. Clin Exp Vaccine Res (2014) 3(1):1-4. doi:10.7774/cevr.2014.3.1.1
10. Kennedy RB, Poland GA. The top five "game changers" in vaccinology: toward rational and directed vaccine development. OMICS (2011) 15(9):533-7. doi:10.1089/omi.2011.0012
11. Lepenies B, Yin J, Seeberger PH. Applications of synthetic carbohydrates to chemical biology. Curr Opin Chem Biol (2010) 14(3):404-11. doi:10.1016/j. cbpa.2010.02.016
12. Pardee K, Slomovic S, Nguyen PQ, Lee JW, Donghia N, Burrill D, et al. Portable, on-demand biomolecular manufacturing. Cell (2016) 167(1):248-59.e12. doi:10.1016/j.cell.2016.09.013
13. Burton DR. What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise. Cold Spring Harb Perspect Biol (2017) 9(11). doi:10.1101/cshperspect.a030262
14. Rappuoli R, Bottomley MJ, D'Oro U, Finco O, De Gregorio E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med (2016) 213(4):469-81. doi:10.1084/jem.20151960
15. Blohmke CJ, O'Connor D, Pollard AJ. The use of systems biology and immunological big data to guide vaccine development. Genome Med (2015) 7:114. doi:10.1186/s13073-015-0236-1
16. Horvatic A, Kuleš J, Guillemin N, Galan A, Mrljak V, Bhide M. High-throughput proteomics and the fight against pathogens. Mol Biosyst (2016) 12(8):2373-84. doi:10.1039/c6mb00223d
17. Dwivedi P, Alam SI, Tomar RS. Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections. World J Microbiol Biotechnol (2016) 32(9):155. doi:10.1007/ s11274-016-2107-3
18. Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS (2011) 15(9):625-36. doi:10.1089/omi.2011.0032
19. Wang Z, Gerstein M, Snyder MRNA-. Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 10(1):57-63. doi:10.1038/nrg2484
20. Yaari G, Kleinstein SH. Practical guidelines for B-cell receptor repertoire sequencing analysis. Genome Med (2015) 7:121. doi:10.1186/ s13073-015-0243-2
21. Woodsworth DJ, Castellarin M, Holt RA. Sequence analysis of T-cell repertoires in health and disease. Genome Med (2013) 5(10):98. doi:10.1186/ gm502
22. Reeves PM, Sluder AE, Paul SR, Scholzen A, Kashiwagi S, Poznansky MC. Application and utility of mass cytometry in vaccine development. FASEB J (2018) 32(1):5-15. doi:10.1096/fj.201700325R
23. Chase BA, Johnston SA, Legutki JB. Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol (2012) 19(3):352-8. doi:10.1128/CVI.05667-11
24. He Y, Rappuoli R, De Groot AS, Chen RT. Emerging vaccine informatics. J Biomed Biotechnol (2010) 2010:218590. doi:10.1155/2010/218590
25. Chattopadhyay PK, Roederer M. A mine is a terrible thing to waste: high content, single cell technologies for comprehensive immune analysis. Am J Transplant (2015) 15(5):1155-61. doi:10.1111/ajt.13193
26. Bragazzi NL. From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and "augmented" medicine: some considerations on Salvatore Iaconesi's clinical story. Patient Prefer Adherence (2013) 7:353-9. doi:10.2147/PPA.S38578
27. Oh H, Rizo C, Enkin M, Jadad A. What is eHealth (3): a systematic review of published definitions. J Med Internet Res (2005) 7(1):e1. doi:10.2196/ jmir.7.1.e1
28. Betsch C, Wicker S. E-health use, vaccination knowledge and perception of own risk: drivers of vaccination uptake in medical students. Vaccine (2012) 30(6):1143-8. doi:10.1016/j.vaccine.2011.12.021
29. Khalili S, Jahangiri A, Borna H, Ahmadi Zanoos K, Amani J. Computational vaccinology and epitope vaccine design by immunoinformatics. Acta Microbiol Immunol Hung (2014) 61(3):285-307. doi:10.1556/AMicr.61.2014.3.4
30. Söllner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, et al. Concept and application of a computational vaccinology workflow. Immunome Res (2010) 6(Suppl 2):S7. doi:10.1186/1745-7580-6-S2-S7
31. Hegde NR, Gauthami S, Sampath Kumar HM, Bayry J. The use of databases, data mining and immunoinformatics in vaccinology: where are we? Expert Opin Drug Discov (2018) 13(2):117-30. doi:10.1080/17460441.2018.1413088
32. He Y, Xiang Z. Databases and in silico tools for vaccine design. Methods Mol Biol (2013) 993:115-27. doi:10.1007/978-1-62703-342-8_8
33. He Y. Vaccine adjuvant informatics: from data integration and analysis to rational vaccine adjuvant design. Front Immunol (2014) 5:32. doi:10.3389/ fimmu.2014.00032
34. Chaudhuri R, Ahmed S, Ansari FA, Singh HV, Ramachandran S. MalVac: database of malarial vaccine candidates. Malar J (2008) 7:184. doi:10.1186/1475-2875-7-184
35. Todd T, Dunn N, Xiang Z, He Y. Vaxar: a web-based database of laboratory animal responses to vaccinations and its application in the meta-analysis of different animal responses to tuberculosis vaccinations. Comp Med (2016) 66(2):119-28
36. Sayers S, Ulysse G, Xiang Z, He Y. Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development. J Biomed Biotechnol (2012) 2012:831486. doi:10.1155/2012/831486
37. Xiang Z, Todd T, Ku KP, Kovacic BL, Larson CB, Chen F, et al. VIOLIN: vaccine investigation and online information network. Nucleic Acids Res (2008) 36(Database issue):D923-8. doi:10.1093/nar/gkm1039
38. He Y, Xiang Z. Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN. Immunome Res (2010) 6(Suppl 1):S5. doi:10.1186/1745-7580-6-S1-S5
39. He Y, Racz R, Sayers S, Lin Y, Todd T, Hur J, et al. Updates on the web-based VIOLIN vaccine database and analysis system. Nucleic Acids Res (2014) 42(Database issue):D1124-32. doi:10.1093/nar/gkt1133
40. Vivona S, Bernante F, Filippini F. NERVE: new enhanced reverse vaccinology environment. BMC Biotechnol (2006) 6:35. doi:10.1186/1472-6750-6-35
41. He Y, Xiang Z, Mobley HL. Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 2010:297505. doi:10.1155/2010/297505
42. Goodswen SJ, Kennedy PJ, Ellis JT. Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology. Bioinformatics (2014) 30(16):2381-3. doi:10.1093/ bioinformatics/btu300
43. Jaiswal V, Chanumolu SK, Gupta A, Chauhan RS, Rout C. Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions. BMC Bioinformatics (2013) 14:211. doi:10.1186/1471-2105-14-211
44. Schubert B, Brachvogel HP, Jürges C, Kohlbacher O. EpiToolKit-a web-based workbench for vaccine design. Bioinformatics (2015) 31(13):2211-3. doi:10.1093/bioinformatics/btv116
45. Moise L, Gutierrez A, Kibria F, Martin R, Tassone R, Liu R, et al. iVAX: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Hum Vaccin Immunother (2015) 11(9): 2312-21. doi:10.1080/21645515.2015.1061159
46. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics (2007) 8:4. doi:10.1186/1471-2105-8-4
47. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med (2003) 197(6):789-99. doi:10.1084/ jem.20021911
48. Nakai K, Kanehisa M. Expert system for predicting protein localization sites in gram-negative bacteria. Proteins (1991) 11(2):95-110. doi:10.1002/ prot.340110203
49. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 25(17):3389-402. doi:10.1093/nar/25.17.3389
50. Yang HL, Zhu YZ, Qin JH, He P, Jiang XC, Zhao GP, et al. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics (2006) 7:293. doi:10.1186/1471-2164-7-293
51. Grassmann AA, Kremer FS, Dos Santos JC, Souza JD, Pinto LDS, McBride AJA. Discovery of novel leptospirosis vaccine candidates using reverse and structural vaccinology. Front Immunol (2017) 8:463. doi:10.3389/ fimmu.2017.00463
52. Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine (2007) 25(16):2963-73. doi:10.1016/j. vaccine.2007.01.065
53. Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P. Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach. Appl Biochem Biotechnol (2014) 172(6):3026-41. doi:10.1007/s12010-014-0749-x
54. Tuju J, Kamuyu G, Murungi LM, Osier FHA. Vaccine candidate discovery for the next generation of malaria vaccines. Immunology (2017) 152(2):195-206. doi:10.1111/imm.12780
55. Merrifield M, Hotez PJ, Beaumier CM, Gillespie P, Strych U, Hayward T, et al. Advancing a vaccine to prevent human schistosomiasis. Vaccine (2016) 34(26):2988-91. doi:10.1016/j.vaccine.2016.03.079
56. Gan W, Zhao G, Xu H, Wu W, Du W, Huang J, et al. Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate. Parasitol Res (2010) 106(4):873-82. doi:10.1007/s00436-010-1729-x
57. Caro-Gomez E, Gazi M, Goez Y, Valbuena G. Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach. Vaccine (2014) 32(39):4968-76. doi:10.1016/j.vaccine.2014.06.089
58. Pandey K, Sharma M, Saarav I, Singh S, Dutta P, Bhardwaj A, et al. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach. Int J Mycobacteriol (2016) 5(1):34-43. doi:10.1016/j.ijmyco.2015.10.005
59. Hassan A, Naz A, Obaid A, Paracha RZ, Naz K, Awan FM, et al. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. BMC Genomics (2016) 17(1):732. doi:10.1186/s12864-016-2951-4
60. Moriel DG, Tan L, Goh KG, Phan MD, Ipe DS, Lo AW, et al. Novel protective vaccine antigen from the core Escherichia coli genome. mSphere (2016) 1(6):1-13. doi:10.1128/mSphere.00326-16
61. Holtfreter S, Kolata J, Stentzel S, Bauerfeind S, Schmidt F, Sundaramoorthy N, et al. Omics approaches for the study of adaptive immunity to Staphylococcus aureus and the selection of vaccine candidates. Proteomes (2016) 4(1):1-25. doi:10.3390/proteomes4010011
62. Oprea M, Antohe F. Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine. Biologicals (2013) 41(3):148-53. doi:10.1016/j.biologicals.2013.03.001
63. Soares SC, Trost E, Ramos RT, Carneiro AR, Santos AR, Pinto AC, et al. Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production. J Biotechnol (2013) 167(2):135-41. doi:10.1016/j. jbiotec.2012.11.003
64. Xiang Z, He Y. Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology. BMC Bioinformatics (2013) 14(Suppl 4):S2. doi:10.1186/1471-2105-14-S4-S2
65. Barh D, Barve N, Gupta K, Chandra S, Jain N, Tiwari S, et al. Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds. PLoS One (2013) 8(1):e52773. doi:10.1371/journal.pone.0052773
66. Ifeonu OO, Simon R, Tennant SM, Sheoran AS, Daly MC, Felix V, et al. Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates. Database (Oxford) (2016) 2016:1-13. doi:10.1093/database/baw137
67. Goodswen SJ, Kennedy PJ, Ellis JT. Discovering a vaccine against neosporosis using computers: is it feasible? Trends Parasitol (2014) 30(8):401-11. doi:10.1016/j.pt.2014.06.004
68. Goodswen SJ, Kennedy PJ, Ellis JT. On the application of reverse vaccinology to parasitic diseases: a perspective on feature selection and ranking of vaccine candidates. Int J Parasitol (2017) 47(12):779-90. doi:10.1016/j. ijpara.2017.08.004
69. Andreotti R, Giachetto PF, Cunha RC. Advances in tick vaccinology in Brazil: from gene expression to immunoprotection. Front Biosci (Schol Ed) (2018) 10:127-42. doi:10.2741/s504
70. Aguirre Ade A, Lobo FP, Cunha RC, Garcia MV, Andreotti R. Design of the ATAQ peptide and its evaluation as an immunogen to develop a Rhipicephalus vaccine. Vet Parasitol (2016) 221:30-8. doi:10.1016/j.vetpar.2016.02.032
71. Maritz-Olivier C, van Zyl W, Stutzer C. A systematic, functional genomics, and reverse vaccinology approach to the identification of vaccine candidates in the cattle tick, Rhipicephalus microplus. Ticks Tick Borne Dis (2012) 3(3):179-87. doi:10.1016/j.ttbdis.2012.01.003
72. Liebenberg J, Pretorius A, Faber FE, Collins NE, Allsopp BA, van Kleef M. Identification of Ehrlichia ruminantium proteins that activate cellular immune responses using a reverse vaccinology strategy. Vet Immunol Immunopathol (2012) 145(1-2):340-9. doi:10.1016/j.vetimm.2011.12.003
73. Sebatjane SI, Pretorius A, Liebenberg J, Steyn H, Van Kleef M. In vitro and in vivo evaluation of five low molecular weight proteins of Ehrlichia ruminantium as potential vaccine components. Vet Immunol Immunopathol (2010) 137(3-4):217-25. doi:10.1016/j.vetimm.2010.05.011
74. Palmeira L, Machiels B, Lété C, Vanderplasschen A, Gillet L. Sequencing of bovine herpesvirus 4 v.test strain reveals important genome features. Virol J (2011) 8:406. doi:10.1186/1743-422X-8-406
75. Altindis E, Cozzi R, Di Palo B, Necchi F, Mishra RP, Fontana MR, et al. Protectome analysis: a new selective bioinformatics tool for bacterial vaccine candidate discovery. Mol Cell Proteomics (2015) 14(2):418-29. doi:10.1074/ mcp.M114.039362
76. Lloyd J, Cheyne J. The origins of the vaccine cold chain and a glimpse of the future. Vaccine (2017) 35(17):2115-20. doi:10.1016/j.vaccine.2016.11.097
77. Vangroenweghe F. Good vaccination practice: it all starts with a good vaccine storage temperature. Porcine Health Manag (2017) 3:24. doi:10.1186/ s40813-017-0071-4
78. Hatchett R. The medicines refrigerator and the importance of the cold chain in the safe storage of medicines. Nurs Stand (2017) 32(6):53-63. doi:10.7748/ ns.2017.e10960
79. Rolfhamre P, Jansson A, Arneborn M, Ekdahl K. SmiNet-2: description of an internet-based surveillance system for communicable diseases in Sweden. Euro Surveill (2006) 11(5):103-7. doi:10.2807/esm.11.05.00626-en
80. Faensen D, Claus H, Benzler J, Ammon A, Pfoch T, Breuer T, et al. SurvNet@ RKI-a multistate electronic reporting system for communicable diseases. Euro Surveill (2006) 11(4):100-3. doi:10.2807/esm.11.04.00614-en
81. Nuti SV, Wayda B, Ranasinghe I, Wang S, Dreyer RP, Chen SI, et al. The use of Google Trends in health care research: a systematic review. PLoS One (2014) 9(10):e109583. doi:10.1371/journal.pone.0109583
82. Althouse BM, Scarpino SV, Meyers LA, Ayers JW, Bargsten M, Baumbach J, et al. Enhancing disease surveillance with novel data streams: challenges and opportunities. EPJ Data Sci (2015) 4:17. doi:10.1140/epjds/s13688-015-0054-0
83. Seo DW, Shin SY. Methods using social media and search queries to predict infectious disease outbreaks. Healthc Inform Res (2017) 23(4):343-8. doi:10.4258/hir.2017.23.4.343
84. Samaras L, García-Barriocanal E, Sicilia MA. Syndromic surveillance models using web data: the case of influenza in Greece and Italy using Google Trends. JMIR Public Health Surveill (2017) 3(4):e90. doi:10.2196/publichealth.8015
85. Yang S, Santillana M, Kou SC. Accurate estimation of influenza epidemics using Google search data via ARGO. Proc Natl Acad Sci U S A (2015) 112(47):14473-8. doi:10.1073/pnas.1515373112
86. Zhang Y, Milinovich G, Xu Z, Bambrick H, Mengersen K, Tong S, et al. monitoring pertussis infections using Internet search queries. Sci Rep (2017) 7(1):10437. doi:10.1038/s41598-017-11195-z
87. Pollett S, Wood N, Boscardin WJ, Bengtsson H, Schwarcz S, Harriman K, et al. Validating the use of Google Trends to enhance pertussis surveillance in California. PLoS Curr (2015) 7. doi:10.1371/currents. outbreaks.7119696b3e7523faa4543faac87c56c2
88. Warren KE, Wen LS. Measles, social media and surveillance in Baltimore City. J Public Health (Oxf) (2017) 39(3):e73-8. doi:10.1093/pubmed/fdw076
89. Haks MC, Bottazzi B, Cecchinato V, De Gregorio C, Del Giudice G, Kaufmann SHE, et al. Molecular signatures of immunity and immunogenicity in infection and vaccination. Front Immunol (2017) 8:1563. doi:10.3389/ fimmu.2017.01563
90. Dunachie S, Berthoud T, Hill AV, Fletcher HA. Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model. Vaccine (2015) 33(40):5321-31. doi:10.1016/j.vaccine.2015.07.087
91. Atkinson KM, El-Khatib Z, Barnum G, Bell C, Turcotte MC, Murphy MSQ, et al. Using mobile apps to communicate vaccination records: a city-wide evaluation with a national immunization app, maternal child registry and public health authorities. Healthc Q (2017) 20(3):41-6. doi:10.12927/ hcq.2017.25289
92. Chandler RE. Safety concerns with HPV vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient? Drug Safety (2017) 40(12):1167-70. doi:10.1007/s40264-017-0610-6
93. Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J (2009) 28(5):431-2. doi:10.1097/INF.0b013e3181a6a511
94. Whitaker JA, Ovsyannikova IG, Poland GA. Adversomics: a new paradigm for vaccine safety and design. Expert Rev Vaccines (2015) 14(7):935-47. doi: 10.1586/14760584.2015.1038249
95. Berendsen MLT, Smits J, Netea MG, van der Ven A. Non-specific effects of vaccines and stunting: timing may be essential. EBioMedicine (2016) 8:341-8. doi:10.1016/j.ebiom.2016.05.010
96. Xie J, He Y. Ontology-based vaccine adverse event representation and analysis. Adv Exp Med Biol (2017) 1028:89-103. doi:10.1007/978-981-10-6041-0_6
97. He Y, Ong E, Xie J. Integrative representations and analyses of vaccine-induced intended protective immunity and unintended adverse events using ontology-based and theory-guided approaches. Glob Vaccines Immunol (2016) 1(2):37-9. doi:10.15761/GVI.1000110
98. Bragazzi NL, Barberis I, Rosselli R, Gianfredi V, Nucci D, Moretti M, et al. How often people Google for vaccination: qualitative and quantitative insights from a systematic search of the web-based activities using Google Trends. Hum Vaccin Immunother (2017) 13(2):464-9. doi:10.1080/2164551 5.2017.1264742
99. Amicizia D, Domnich A, Gasparini R, Bragazzi NL, Lai PL, Panatto D. An overview of current and potential use of information and communication technologies for immunization promotion among adolescents. Hum Vaccin Immunother (2013) 9(12):2634-42. doi:10.4161/hv.26010
100. Rosselli R, Martini M, Bragazzi NL. The old and the new: vaccine hesitancy in the era of the Web 2.0. Challenges and opportunities. J Prev Med Hyg (2016) 57(1):E47-50
101. Shah MP, Lopman BA, Tate JE, Harris J, Esparza-Aguilar M, Sanchez-Uribe E, et al. Use of internet search data to monitor rotavirus vaccine impact in the United States, United Kingdom, and Mexico. J Pediatric Infect Dis Soc (2018) 7(1):56-63. doi:10.1093/jpids/pix004
102. Bakker KM, Martinez-Bakker ME, Helm B, Stevenson TJ. Digital epidemiology reveals global childhood disease seasonality and the effects of immunization. Proc Natl Acad Sci U S A (2016) 113(24):6689-94. doi:10.1073/ pnas.1523941113
103. Goldlust S, Lee E, Bansal S. Assessing the distribution and drivers of vaccine hesitancy using medical claims data. Online J Public Health Inform (2017) 9(1):e012. doi:10.5210/ojphi.v9i1.7590
104. Larson HJ, Smith DM, Paterson P, Cumming M, Eckersberger E, Freifeld CC, et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis (2013) 13(7):606-13. doi:10.1016/S1473-3099(13)70108-7
105. van Panhuis WG, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med (2013) 369(22):2152-8. doi:10.1056/NEJMms1215400
106. Shrestha S, Foxman B, Berus J, van Panhuis WG, Steiner C, Viboud C, et al. The role of influenza in the epidemiology of pneumonia. Sci Rep (2015) 5:15314. doi:10.1038/srep15314
107. Kata A. A postmodern Pandora's box: anti-vaccination misinformation on the Internet. Vaccine (2010) 28(7):1709-16. doi:10.1016/j.vaccine.2009.12.022
108. Butler D. When Google got flu wrong. Nature (2013) 494(7436):155-6. doi:10.1038/494155a
109. Santillana M, Zhang DW, Althouse BM, Ayers JW. What can digital disease detection learn from (an external revision to) Google Flu Trends? Am J Prev Med (2014) 47(3):341-7. doi:10.1016/j.amepre.2014.05.020
110. Milton CL. The ethics of big data and nursing science. Nurs Sci Q (2017) 30(4):300-2. doi:10.1177/0894318417724474
111. Lipworth W, Mason PH, Kerridge I. Ethics and epistemology of big data. J Bioeth Inq (2017) 14(4):485-8. doi:10.1007/s11673-017-9815-8